Form 8-K - Current report:
SEC Accession No. 0001213900-15-009637
Filing Date
2015-12-22
Accepted
2015-12-22 08:00:45
Documents
3
Period of Report
2015-12-17
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k121715_immucellcorp.htm 8-K 26152
2 PRESS RELEASE OF IMMUCELL CORPORATION DATED DECEMBER 22, 2015 f8k121715ex99i_immucellcorp.htm EX-99.1 12819
3 PRODUCT DEVELOPMENT CONTRACT MANUFACTURE AGREEMENT f8k121715ex99ii_immucellcorp.htm EX-99.2 151794
  Complete submission text file 0001213900-15-009637.txt   191799
Mailing Address 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address 56 EVERGREEN DR PORTLAND ME 04103 2078782770
IMMUCELL CORP /DE/ (Filer) CIK: 0000811641 (see all company filings)

IRS No.: 010382980 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12934 | Film No.: 151300839
SIC: 2835 In Vitro & In Vivo Diagnostic Substances